DLX-159 is a putatively non-hallucinogenic psychoplastogen of the tryptamine family which is under development for the treatment of major depressive disorder and other psychiatric disorders.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.